3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
70
Rectal Neoplasms
29
Colonic Neoplasms
28
Carcinoma, Hepatocellular
26
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
7
Cholangiocarcinoma
6
Adenocarcinoma Of Esophagus
6
Esophageal Neoplasms
5
Recurrence
4
Liver Neoplasms
4
Biliary Tract Neoplasms
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Gastrointestinal Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Adenocarcinoma
2
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Oligometastatic Gastric Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neuropathy, Painful
1
Neuralgia
1
Interventions
Cyclophosphamide
21
Cytarabine
15
blinatumomab
13
fludarabine
12
Azacitidine
10
venetoclax
9
fludarabine phosphate
9
Blood Specimen Collection
8
Methotrexate
7
Lenalidomide
7
Dexamethasone
7
Rituximab
6
Mercaptopurine
6
Daunorubicin
6
Vincristine
5
daratumumab
4
Whole-Body Irradiation
4
Melphalan
4
Etoposide
4
Busulfan
4
obinutuzumab
3
Radiotherapy
3
Neoadjuvant Therapy
3
Maintenance
3
Liquid Biopsy
3
Immunotherapy, Adoptive
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Drug Therapy
3
Doxorubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm, Residual
×
Folfox protocol
×
Clear all
NCT05534087
2024-11-29
CLAUDIA
Seoul National University Hospital
Phase 3
Recruiting
236 enrolled